Thomas McGrath
      OUR PEOPLE

      Dr. Thomas McGrath

      PhD in Chemistry

      Global Head of Scientific and Medical Affairs Strategic Operations and Excellence

      Contact

      Thomas graduated from the University of Ulster, Northern Ireland, with a first class honors degree in Science with Business and obtained his PhD in Chemistry from Brown University, Rhode Island, U.S. He also holds a Diploma in Industrial Studies.

      He joined Philip Morris International (PMI) in 2005 as a Senior Research Scientist focusing on the development of Next Generation Products*. Since then he has worked in a variety of strategic roles focused on the design, development, assessment, and commercialization of PMI’s portfolio of smoke-free products.

      Currently, as the Global Head of Scientific and Medical Affairs Strategic Operations and Excellence, Thomas is responsible for ensuring the highest standards of scientific integrity and operational effectiveness in PMI's research and development initiatives.

      With over a decade of dedicated research in the field of smoke-free alternatives, his work has been published in numerous peer-reviewed journals and presented at international scientific conferences.

       

      *Next Generation Products is another term that refers to smoke-free products.

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.